89 results
Page 2 of 5
8-K
EX-99.1
mort7n5t a3qjc99
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am
8-K
EX-99.1
sss3mnp1a5exh3bvcsz
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
EX-99.1
ea73q3
10 Aug 23
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
is571ru2
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
lid s5i1j2s3jbh
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
EX-99.1
11x0qidwq pm4xy8
30 Mar 23
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
4:15pm
8-K
EX-99.1
rsidusyrm7u9tpq
10 Nov 22
Pulse Biosciences Reports Third Quarter 2022 Financial Results
4:20pm
8-K
w90s1e
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
EX-99.1
b6o0zl6jemrtsw
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
424B5
57nc6 oq5b47d
4 May 22
Prospectus supplement for primary offering
8:40am
8-K
lpsoseodq 6z
14 Apr 22
Pulse Biosciences, Inc. Announces Rights Offering
4:23pm